A Review of the Strategies and Studies on the Prevention and Control of the New Coronavirus in Workplaces



Occupational Medicine Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran


Workplaces are susceptible places for exposure to the new coronavirus (Covid-19) infection due to gathering of many
people. Hence, different instructions have been promoted by international organizations regarding high-risk employees
and the necessity of implementing health policies to prevent exposure and infection in the workplace. Here we reviewed
the required strategies to prevent and control COVID-19 in the workplace. In conclusion, considering the fast spreading
and growing prevalence of the new corona virus disease in the world over, all managers, employers, and business
owners should receive the necessary information and training on prevention and control strategies based on scientific
guidelines and standards.
Level of evidence: III


1. Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S, et al.
Detection of Covid-19 in children in early January 2020
in Wuhan, China. N Engl J Med. 2020; 382(14):1370-1.
2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.
Clinical characteristics of coronavirus disease 2019 in
China. N Engl J Med. 2020; In Press.
3. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al.
A familial cluster of pneumonia associated with the
2019 novel coronavirus indicating person-to-person
transmission: a study of a family cluster. Lancet. 2020;
4. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed
asymptomatic carrier transmission of COVID-19.
JAMA. 2020; In Press.
5. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of
COVID‐19 based on current evidence. J Med Virol.
2020; In Press.
6. Habibzadeh P, Stoneman EK. The novel coronavirus:
a bird’s eye view. Int J Occup Environ Med. 2020;
7. Guidance on preparing workplaces for COVID-19.
Occupational Safety and Health Administration
(OSHA). Available at: URL: https://www.osha.gov/
Publications/OSHA3990.pdf; 2020.
8. CDC Industry Guidance. Interim guidance for
businesses and employers to plan and respond to
coronavirus disease 2019 (COVID-19). Available
at: URL: https://healthalliancesjc.org/wp-content/
Disease-2019-COVID-19-February-2.-1.pdf; 2020.
9. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
characteristics of 138 hospitalized patients with 2019
novel coronavirus–infected pneumonia in Wuhan,
China. JAMA. 2020; In Press.
10. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission
routes of 2019-nCoV and controls in dental practice.
Int J Oral Sci. 2020; 12(1):9.
11. Mizumoto K, Chowell G. Transmission potential of the
novel coronavirus (COVID-19) onboard the diamond
princess cruises ship, 2020. Infect Dis Model. 2020;
12. Liem A, Wang C, Wariyanti Y, Latkin CA, Hall BJ. The
neglected health of international migrant workers
in the COVID-19 epidemic. Lancet Psychiatry. 2020;
13. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of
COVID‐19 based on current evidence. J Med Virol.
2020; In Press.
14. Paull B. COVID-19–what employers need to know.
Burness Paull. Available at: URL: https://www.
19-what-employers-need-to-know; 2020.
15. Baker MG, Peckham TK, Seixas NS. Estimating the
burden of United States workers exposed to infection
or disease: a key factor in containing risk of COVID-19
infection. Med Rxiv. 2020; In Press.
16. Sun H, Dickens BL, Chen M, Cook AR, Clapham 
HE. Estimating number of global importations of
COVID-19 from Wuhan, risk of transmission outside
mainland China and COVID-19 introduction index
between countries outside Mainland China. Med Rxiv.
2020; In Press.
17. Public Health Ontario. Updated IPAC recommendations
for use of personal protective equipment for care of
individuals with suspect or confirmed COVID-19.
Available at: URL: https://www.publichealthontario.
covid-19.pdf?la=en; 2020.
18. Joob B, Wiwanitkit V. COVID-19 in medical personnel:
observation from Thailand. J Hosp Infect. 2020; In
19. Shigemura J, Ursano RJ, Morganstein JC, Kurosawa
M, Benedek DM. Public responses to the Novel 2019
coronavirus (2019‐nCoV) in Japan: mental health
consequences and target populations. Psychiatry Clin
Neurosci. 2020; 74(4):281-2.
20. Imai H. Trust is a key factor in the willingness of health
professionals to work during the COVID‐19 outbreak:
experience from the H1N1 pandemic in Japan 2009.
Psychiatry Clin Neurosci. 2020; In Press.
21. Fadel M, Salomon J, Descatha A. Coronavirus outbreak:
the role of companies in preparedness and responses.
Lancet Public Health. 2020; 5(4):e193.
Volume 8, Supplement 1
April 2020
Pages 242-246
  • Receive Date: 28 March 2020
  • Revise Date: 11 April 2020
  • Accept Date: 10 April 2020
  • First Publish Date: 10 April 2020